[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 880,027
  • Shares Outstanding, K 51,919
  • Annual Sales, $ 107,460 K
  • Annual Income, $ 105,900 K
  • EBIT $ -4 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.19
  • Price/Sales 8.21
  • Price/Cash Flow N/A
  • Price/Book 3.02

Options Overview Details

View History
  • Implied Volatility 63.68% (+4.92%)
  • Historical Volatility 3.43%
  • IV Percentile 20%
  • IV Rank 13.67%
  • IV High 303.44% on 02/20/26
  • IV Low 25.70% on 06/29/26
  • Expected Move (DTE 28) 0.00 (0.00%)
  • Put/Call Vol Ratio 24.69
  • Today's Volume 334
  • Volume Avg (30-Day) 163
  • Put/Call OI Ratio 3.88
  • Today's Open Interest 3,638
  • Open Int (30-Day) 3,100
  • Expected Range 17.01 to 17.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.19
  • Number of Estimates 2
  • High Estimate $0.29
  • Low Estimate $0.09
  • Prior Year $-0.03
  • Growth Rate Est. (year over year) +733.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.81 +1.19%
on 07/22/26
17.02 -0.06%
on 08/21/26
+0.17 (+1.01%)
since 07/21/26
3-Month
15.52 +9.60%
on 06/02/26
17.74 -4.11%
on 06/26/26
+0.67 (+4.10%)
since 05/21/26
52-Week
13.08 +30.05%
on 03/03/26
21.03 -19.12%
on 01/22/26
+3.35 (+24.52%)
since 08/21/25

Most Recent Stories

More News
TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

TBPH : 17.01 (+0.35%)
Theravance Bio: Q2 Earnings Snapshot

Theravance Bio: Q2 Earnings Snapshot

TBPH : 17.01 (+0.35%)
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

DUBLIN , Aug. 10, 2026 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the second quarter...

TBPH : 17.01 (+0.35%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBPH, IRDM, LCII, and PATK

NEW YORK , July 9, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

IRDM : 48.98 (+1.09%)
TBPH : 17.01 (+0.35%)
LCII : 101.98 (-3.28%)
PATK : 83.41 (-2.42%)
Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

IRDM : 48.98 (+1.09%)
TBPH : 17.01 (+0.35%)
TECH : 72.32 (+0.06%)
SYNA : 97.66 (-0.35%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH)

NEW YORK , June 29, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

TBPH : 17.01 (+0.35%)
TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

TBPH : 17.01 (+0.35%)
Shareholder Alert: Ademi LLP investigates whether Theravance Biopharma, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , June 29, 2026 /PRNewswire/ -- Ademi LLP is investigating Theravance Biopharma (NASDAQ: TBPH) for possible breaches of fiduciary duty and other violations of law in its recently announced...

TBPH : 17.01 (+0.35%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH). Such investors are...

TBPH : 17.01 (+0.35%)
Theravance Bio: Q1 Earnings Snapshot

Theravance Bio: Q1 Earnings Snapshot

TBPH : 17.01 (+0.35%)

Business Summary

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'...

See More

Key Turning Points

3rd Resistance Point 17.09
2nd Resistance Point 17.06
1st Resistance Point 17.03
Last Price 17.01
1st Support Level 16.97
2nd Support Level 16.94
3rd Support Level 16.91

See More

52-Week High 21.03
Fibonacci 61.8% 17.99
Fibonacci 50% 17.06
Last Price 17.01
Fibonacci 38.2% 16.12
52-Week Low 13.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.